Latest Health News

Cardiex reported strong growth in its Pulse arterial health monitor sales during Q4 FY25, surpassing A$0.7 million for the year and advancing its transition to subscription-based digital health services.

Unibail-Rodamco-Westfield reports robust H1-2025 results with tenant sales growth, portfolio valuation gains, and strategic brand expansion underpinning confidence in full-year earnings guidance.

Cardiex Limited reported a $3 million cash outflow in Q4 2025 but is banking on cost reductions and new product sales to improve its financial footing. The company also secured $6.5 million through a capital raise to bolster its runway.

Oldfields Holdings reports constrained Q4 FY2025 sales due to limited working capital but signals a positive growth outlook for FY2026 following its strategic transformation and capital support.

Adherium Limited reports a robust 30% increase in US remote patient monitoring users and closes a $4.5 million capital raise, positioning itself for accelerated growth under new leadership.

Health and Plant Protein Group Ltd (HPP) ended FY25 Q4 with a strong cash position following a significant IRS payment, while signaling plans for shareholder returns and confidential corporate opportunities.

Oakridge International reported robust revenue growth and expanded its partner network in Q4 2025, underpinning a promising outlook in healthcare technology. The company also advanced product innovation aligned with new industry standards.

Clean TeQ Water Limited reported solid progress across multiple key projects and improved cash receipts in its Q4 FY25 update, underscoring its growing foothold in advanced water treatment and resource recovery.

DGR Global Limited reports steady progress in project generation and subsidiary investments, bolstered by a $23.5 million loan facility and a favorable legal appeal outcome. The company maintains a strong health, safety, and environmental record while navigating challenging market conditions.

Weebit Nano reports solid progress in Q4 FY25 with key technology milestones and its first product design license, backed by a strong cash position.

Skin Elements Limited advances its proprietary SE Formula biotechnology with ECO-Nurture poised for commercial rollout in 2026, alongside progress in disinfectant and sunscreen product lines.

Mustera Property Group advances its North Fremantle McCabe Street project with a planned sales launch in Q3 2025, while settling two Forbes Residences units for $4.6 million, underpinning positive cash flow and refinancing benefits.